restructur keep pace w/street
share close tuesday follow releas result guidanc
news restructur program vs believ
investor nervou head result prove nayer mostli wrong
reiter equal weight rate higher sale rais pt
confid ep pt vs ep
take right actionsagainst difficult hand
view zimmer mismanag decad head biomet merger
price case mix tough sinc zb adjust oper margin
contract year merger
benefit restructur save manag aim return
least
still somewhat heavi lift go
view margin expans current level seem achiev still
pressur abound manag plan take million oper cost
expens manag believ fairli line street
goals/aspir compani word latest restructur
program seem compani might miss street least
net/net manag right thing easi fix
us seem like manag right path path take time
get wamgr remain perhap
share gain opportun zb could grow bit faster net/net believ
share today fairli price believ market alreadi price return
normal level growth maintain equal weight
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
idc link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight view appoint
bryan hanson ceo posit catalyst chang
believ orchestr turnaround
howev believ transform need
like take multipl year see prospect
signific sale margin expans
limit near-term
upsid case could driven improv
market trend orthoped greater success
improv price trend strateg
downsid case could driven inabl
receiv and/or execut new product approv
deterior price addit fda regulatori
exchang stronger us dollar dilut
zimmer biomet sale ahead street expect driven mainli
upsid knee perform quarter constant currenc basi sale
estim ep ahead expect driven
combin incom due pension incom well lower interest expens
due debt pay zb report constant currenc sale growth
guidanc believ street wamgr
zb adjust ep guidanc bracket bloomberg pre-
releas manag announc multi-year restructur believ zb
manag take right step toward acceler growth improv
margin believ mostli reflect stock valuat equal weight
addit detail quarter
million except per share data chang sale constant currenc organ basi unless otherwis note
sale grew report basi street/our estim in-
line compani guidanc rang growth in-lin wamgr
constant currenc basi sale grew driven continu strong perform
apac moder america emea
announc full year sale growth guidanc report
constant currenc basi compani wamgr
knee sale expect due rosa contribut
littl growth strength persona new persona revis
manag announc multi-year restructur plan expect reduc cost
deliv oper margin least expect incur
one-tim cost period
price remain headwind zimmer biomet impact sale growth
overal impact hip impact knee impact spine
cmf impact impact neutral dental
manag note fda re-inspect warsaw north facil record
ep estim aid higher incom lower expect
sale report basi constant currenc
basi constant currenc growth fairli broad-bas knee hip
 spine cmf dental
gross margin y/i driven higher volum favor
sg sale y/i driven sale commiss invest
commerci prioriti
 sale y/i
oper margin bp y/i driven higher sg invest
commerci prioriti knee busi
adjust tax rate y/i
adjust ep street estim
manag note quarter benefit one addit bill day
manag expect sale grow report constant currenc basi neutral impact fx vs street
oper margin expect adjust tax rate expect manag
expect adjust ep vs street
zimmer biomet chart
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- price eros gm per unit cost increaseest target least adjust oper margin barclay zimmer biomet hold inc
addit commentari zimmer biomet call pleas see note
kstew call note restructur upsid need get acceler sale growth
first look better expect sale guid restructur announc
host zimmer biomet confer march pleas see confer websit detail
model pleas see barclay websit link
kristen stewart cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
